These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3092095)

  • 1. Biological evaluation of compounds for their physical dependence potential and abuse liability. IX. Drug Testing Program of the Committee on Problems of Drug Dependence, Inc. (1985).
    Jacobson AE
    NIDA Res Monogr; 1986; 67():385-98. PubMed ID: 3092095
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological evaluation of compounds for their physical dependence potential and abuse liability. XIII. Drug Testing Program of the Committee on Problems of Drug Dependence, Inc.
    Jacobson AE
    NIDA Res Monogr; 1989; 95():556-77. PubMed ID: 2641053
    [No Abstract]   [Full Text] [Related]  

  • 3. Biological evaluation of compounds for their physical dependence potential and abuse liability. XVII. Drug Evaluation Committee of the College on Problems of Drug Dependence, Inc. (1993).
    Jacobson AE
    NIDA Res Monogr; 1994; 140():179-95. PubMed ID: 8722465
    [No Abstract]   [Full Text] [Related]  

  • 4. Biological evaluation of compounds for their physical dependence potential and abuse liability. XII. Drug testing program of the Committee on Problems of Drug Dependence, Inc. (1988).
    Jacobson A
    NIDA Res Monogr; 1988; 90():392-420. PubMed ID: 2908336
    [No Abstract]   [Full Text] [Related]  

  • 5. Biological evaluation of compounds for their physical dependence potential and abuse liability. XI. Drug testing program of the Committee on Problems of Drug Dependence, Inc. (1987).
    Jacobson A
    NIDA Res Monogr; 1988; 81():466-84. PubMed ID: 2900468
    [No Abstract]   [Full Text] [Related]  

  • 6. Biological evaluation of compounds for their physical dependence potential and abuse liability. XIV. Animal Testing Committee of the Committee on Problems of Drug Dependence, Inc. (1990).
    Jacobson AE
    NIDA Res Monogr; 1990; 105():622-39. PubMed ID: 1876149
    [No Abstract]   [Full Text] [Related]  

  • 7. Biological evaluation of compounds for their physical dependence potential and abuse liability. XVI. Drug Evaluation Committee of the College of Problems of Drug Dependence, Inc. (1992).
    Jacobson AE
    NIDA Res Monogr; 1993; 132():437-58. PubMed ID: 8101975
    [No Abstract]   [Full Text] [Related]  

  • 8. Biological evaluation of compounds for their physical dependence potential and abuse liability, XIV. Animal Testing Committee of the Committee on Problems of Drug Dependence, Inc. (1991).
    Jacobson AE
    NIDA Res Monogr; 1992; 119():490-512. PubMed ID: 1435983
    [No Abstract]   [Full Text] [Related]  

  • 9. Biological evaluation of compounds for their physical dependence potential and abuse liability. VIII. Drug testing program of the Committee on Problems of Drug Dependence, Inc. (1984).
    Jacobson AE
    NIDA Res Monogr; 1984; 55():298-308. PubMed ID: 6152698
    [No Abstract]   [Full Text] [Related]  

  • 10. Biological evaluation of compounds for their physical dependence potential and abuse liability. XXI. Drug evaluation committee of the college on problems of drug dependence (1997).
    Jacobson AE
    NIDA Res Monogr; 1998 Mar; 178():346-62. PubMed ID: 9686403
    [No Abstract]   [Full Text] [Related]  

  • 11. Testing drugs for physical dependence potential and abuse liability. The Committee on Problems of Drug Dependence, Inc.
    NIDA Res Monogr; 1984; 52():1-153. PubMed ID: 6148699
    [No Abstract]   [Full Text] [Related]  

  • 12. Biological evaluation of compounds for their dependence liability. V. Drug testing program of the Committee on Problems of Drug Dependence, Inc. (1981).
    Jacobson AE
    NIDA Res Monogr; 1982 Apr; 41():331-7. PubMed ID: 6811928
    [No Abstract]   [Full Text] [Related]  

  • 13. Annual report: biological evaluation of compounds for their dependence liability. IV. Drug testing program of the Committee on Problems of Drug, Dependence, Inc. (1980).
    Jacobson AE
    NIDA Res Monogr; 1981 Feb; 34():287-96. PubMed ID: 6783943
    [No Abstract]   [Full Text] [Related]  

  • 14. Biological evaluation of compounds for their dependence liability. VI. Drug testing program of the Committee on Problems of Drug Dependence, Inc. (1982).
    Jacobson AE
    NIDA Res Monogr; 1983 Apr; 43():389-98. PubMed ID: 6410274
    [No Abstract]   [Full Text] [Related]  

  • 15. Biological evaluation of compounds for their dependence liability. VII. Drug Testing Program of the Committee on Problems of Drug dependence, Inc. (1983).
    Jacobson AE
    NIDA Res Monogr; 1984 Mar; 49():352-60. PubMed ID: 6148694
    [No Abstract]   [Full Text] [Related]  

  • 16. Biological evaluation of compounds for their physical dependence potential and abuse liability. X. Drug testing programs of the Committee on Problems of Drug Dependence, Inc. (1986).
    Jacobson AE
    NIDA Res Monogr; 1987; 76():370-91. PubMed ID: 2893982
    [No Abstract]   [Full Text] [Related]  

  • 17. Annual report: biological testing program of the Committee on Problems of Drug Dependence, Inc. (1979).
    Jacobson AE
    NIDA Res Monogr; 1979; 27():351-5. PubMed ID: 121357
    [No Abstract]   [Full Text] [Related]  

  • 18. Dependence studies of new compounds in the rhesus monkey, rat, and mouse (1985).
    Aceto MD; Harris LS; May EL
    NIDA Res Monogr; 1986; 67():399-452. PubMed ID: 3092096
    [No Abstract]   [Full Text] [Related]  

  • 19. Results of random drug testing in an adolescent substance abuse program.
    Levy S; Sherritt L; Vaughan BL; Germak M; Knight JR
    Pediatrics; 2007 Apr; 119(4):e843-8. PubMed ID: 17403828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing for drugs of abuse in children and adolescents. American Academy of Pediatrics Committee on Substance Abuse.
    Pediatrics; 1996 Aug; 98(2 Pt 1):305-7. PubMed ID: 8692638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.